Proton Chemical Shift Imaging in Normal Pressure Hydrocephalus

References

1. ↵
   Mahler CE, Cummings JL, Benson DF. Treatable dementia. West J Med 1987;146:700-712
2. ↵
   Adams RD, Fisher CM, Hakim S, et al. Symptomatic occult hydrocephalus with “normal” cerebrospinal fluid pressure. N Engl J Med 1965;273:117-126
3. Ojemann RG. Normal pressure hydrocephalus. Clin Neurosurg 1970;18:337-370
4. ↵
   Masters JC, O'Grady M. Normal pressure hydrocephalus. A potentially reversible form of dementia. J Psychosoc Nurs Ment Health Serv 1992;30:25-28
5. ↵
   Benson DF, LeMay M, Patten DH, Rubens AB. Diagnosis of normal-pressure hydrocephalus. N Engl J Med 1970;283:609-615
6. ↵
   Vanneste J, Augustijn P, Davies GA, Dirven C, Tan WF. Normal-pressure hydrocephalus. Is cisternography still useful in selecting patients for a shunt? Arch Neurol 1992;49:366-370

   CrossRefPubMedWeb of Science
7. ↵
   Graff-Radford NR, Rezai K, Godersky JC, Eslinger P, Damasio H, Kirchner PT. Regional cerebral blood flow in normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 1987;50:1589-1596

   Abstract/FREE Full Text
8. Larsson A, Bergh AC, Bilting M, et al. Regional cerebral blood flow in normal pressure hydrocephalus: diagnostic and prognostic aspects. Eur J Nucl Med 1994;21:118-123

   PubMedWeb of Science
9. Nakano H, Bandoh K, Miyaoka M, Sato K. Evaluation of hydrocephalic periventricular radiolucency by dynamic computed tomography and xenon-computed tomography. Neurosurgery 1996;39:758-762

   CrossRefPubMedWeb of Science
10. ↵
    Jagust WJ, Friedland RP, Budinger TF. Positron emission tomography with [18F]fluorodeoxyglucose differentiates normal pressure hydrocephalus from Alzheimer-type dementia. J Neurol Neurosurg Psychiatry 1985;48:1091-1096

    Abstract/FREE Full Text
11. Tedeschi E, Hasselbalch SG, Waldemar G, et al. Heterogeneous cerebral glucose metabolism in normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 1995;59:608-615

    Abstract/FREE Full Text
12. ↵
    Bradley WG Jr, Whittemore AR, Watanabe AS, Davis SJ, Teresi LM, Homyak M. Association of deep white matter infarction with chronic communicating hydrocephalus: implications regarding the possible origin of normal-pressure hydrocephalus. Am J Neuroradiol 1991;12:31-39

    Abstract/FREE Full Text
13. Schroth G, Klose U. Cerebrospinal fluid flow. II. Physiology of respiration-related pulsations. Neuroradiology 1992;35:10-15

    CrossRefPubMed
14. ↵
    Krauss JK, Regel JP, Vach W, Jungling FD, Droste DW, Wakhloo AK. Flow void of cerebrospinal fluid in idiopathic normal pressure hydrocephalus of the elderly: can it predict outcome after shunting? Neurosurgery 1997;40:67-73

    PubMed
15. ↵
    Huckman MS. Normal pressure hydrocephalus: evaluation of diagnostic and prognostic tests. Am J Neuroradiol 1981;2:385-395

    Abstract/FREE Full Text
16. ↵
    Black PM, Ojemann RG, Tzouras A. CSF shunts for dementia, incontinence, and gait disturbance. Clin Neurosurg 1985;32:632-651

    PubMed
17. ↵
    Wikkelso C, Andersson H, Blomstrand C, Lindqvist G. The clinical effect of lumbar puncture in normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 1982;45:64-69

    Abstract/FREE Full Text
18. ↵
    Vanneste JA. Diagnosis and management of normal-pressure hydrocephalus. J Neurol 2000;247:5-14

    CrossRefPubMedWeb of Science
19. ↵
    Luyten PR, Marien JH, Heindel W, et al. Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. Radiology 1990;176:791-799

    PubMedWeb of Science
20. Fulham HJ, Bizzi A, Dietz MJ, et al. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 1992;185:675-686

    PubMed
21. Constans JM, Meyerhoff DJ, Gerson J, et al. H-1 MR spectroscopic imaging of white matter signal hyperintensities: Alzheimer disease and ischemic vascular dementia. Radiology 1995;197:517-523

    PubMedWeb of Science
22. ↵
    McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944

    Abstract/FREE Full Text
23. ↵
    The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994;57:416-418

    FREE Full Text
24. ↵
    George AE, Holodny A, Golomb J, de Leon MJ. The differential diagnosis of Alzheimer's disease. Cerebral atrophy versus normal pressure hydrocephalus. Neuroimaging Clin N Am 1995;5:19-31

    PubMed
25. ↵
    Holodny AI, Waxman R, George AE, Rusinek H, Kalnin AJ, de Leon M. MR differential diagnosis of normal-pressure hydrocephalus and Alzheimer disease: significance of perihippocampal fissures. Am J Neuroradiol 1998;19:813-819

    Abstract
26. ↵
    Hakim S, Adams RD. The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics. J Neurol Sci 1965;2:307-327

    CrossRefPubMed
27. ↵
    James AE Jr, Burns B, Flor WF, et al. Pathophysiology of chronic communicating hydrocephalus in dogs (Canis familiaris). Experimental studies. J Neurol Sci 1975;24:151-178

    CrossRefPubMed
28. ↵
    Symon L, Dorsch NW. Use of long-term intracranial pressure measurement to assess hydrocephalic patients prior to shunt surgery. J Neurosurg 1975;42:258-273

    PubMedWeb of Science
29. ↵
    Di Rocco C, McLone DG, Shimoji T, Raimondi AJ. Continuous intraventricular cerebrospinal fluid pressure recording in hydrocephalic children during wakefulness and sleep. J Neurosurg 1975;42:683-689

    PubMedWeb of Science
30. ↵
    Braun KP, de Graaf RA, Vandertop WP, Gooskens RH, Tulleken KA, Nicolay K. In vivo 1H MR spectroscopic imaging and diffusion weighted MRI in experimental hydrocephalus. Magn Reson Med 1998;40:832-839

    PubMed
31. Braun KP, van Eijsden P, Vandertop WP, et al. Cerebral metabolism in experimental hydrocephalus: an in vivo 1H and 31P magnetic resonance spectroscopy study. J Neurosurg 1999;91:660-668

    PubMed
32. Braun KP, Dijkhuizen RM, de Graaf RA, et al. Cerebral ischemia and white matter edema in experimental hydrocephalus: a combined in vivo MRI and MRS study. Brain Res 1997;757:295-298

    CrossRefPubMed
33. ↵
    Wozniak M, McLone DG, Raimondi AJ. Micro- and macrovascular changes as the direct cause of parenchymal destruction in congenital murine hydrocephalus. J Neurosurg 1975;43:535-545

    PubMedWeb of Science
34. ↵
    Bluml S, McComb JG, Ross BD. Differentiation between cortical atrophy and hydrocephalus using 1H MRS. Magn Reson Med 1997;37:395-403

    CrossRefPubMedWeb of Science
35. ↵
    Shonk TK, Moats RA, Gifford P, et al. Probable Alzheimer disease: diagnosis with proton MR spectroscopy. Radiology 1995;195:65-72

    PubMedWeb of Science
36. Adalsteinsson E, Sullivan EV, Kleinhans N, Spielman DM, Pfefferbaum A. Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer's disease. Lancet 2000;355:1696-1697

    CrossRefPubMedWeb of Science
37. Schuff N, Amend D, Ezekiel F, et al. Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study. Neurology 1997;49:1513-1521

    Abstract/FREE Full Text